Neil Brewis
2020
In 2020, Neil Brewis earned a total compensation of $1.7M as Chief Scientific Officer at F-star Therapeutics, a 234% increase compared to previous year.
Compensation breakdown
| Bonus | $247,500 |
|---|---|
| Option Awards | $1,075,000 |
| Salary | $320,937 |
| Other | $25,965 |
| Total | $1,669,402 |
Brewis received $1.1M in option awards, accounting for 64% of the total pay in 2020.
Brewis also received $247.5K in bonus, $320.9K in salary and $26K in other compensation.
Rankings
In 2020, Neil Brewis' compensation ranked 6,353rd out of 13,090 executives tracked by ExecPay. In other words, Brewis earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,353 out of 13,090 | 52nd |
Division Manufacturing | 2,621 out of 5,618 | 53rd |
Major group Chemicals And Allied Products | 1,057 out of 2,251 | 53rd |
Industry group Drugs | 913 out of 1,951 | 53rd |
Industry Pharmaceutical Preparations | 681 out of 1,456 | 53rd |
Source: SEC filing on April 7, 2021.
Brewis' colleagues
We found seven more compensation records of executives who worked with Neil Brewis at F-star Therapeutics in 2020.
2020
Eliot Forster
F-star Therapeutics
Chief Executive Officer
2020
Neil DSc
F-star Therapeutics
Chief Scientific Officer
2020
Louis Kayitalire
F-star Therapeutics
Chief Medical Officer
2020
Darlene Deptula-Hicks
F-star Therapeutics
Chief Financial Officer
2020
RP Iyer
F-star Therapeutics
Chief Scientific Officer
2020
Martin Driscoll
F-star Therapeutics
Chief Executive Officer
2020
Jonathan Freve
F-star Therapeutics